Smart insulin pump shows promise for diabetics with kidney failure
NCT ID NCT06330194
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested an automated insulin delivery system (a smart pump) in 15 adults with type 1 or type 2 diabetes who also had advanced kidney disease or were on dialysis. Participants used the system for 8 weeks, then switched to their usual care for another 8 weeks. The goal was to see if the smart pump could better control blood sugar levels and reduce dangerous lows compared to standard treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Tobias Bomholt
Copenhagen, 2100, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Aging kidneys under the microscope: could a simple test predict failure?
- Could a stress hormone be behind the hidden danger of low blood sugar?
- Can video games and electric pulses ease dialysis Patients' shoulder pain?
- Can a heart drug tame blood sugar and weight in diabetes?
- Could your gut bacteria hold the key to protecting your kidneys?
- Food as medicine: could cooking classes slow kidney disease?